CRISPR THERAPEUTICS AG Cash
CRISPR THERAPEUTICS AG (CRSP) had Cash of $456.65 million as of 2018-12-31, per its 10-K filed 2019-02-25.
Discontinued › Balance Sheet › Assets
us-gaap:Cash · last filed 2019-02-25
- 2018-12-31: Cash $456.65M.
- 2018-09-30: Cash $487.30M.
- 2018-06-30: Cash $319.74M.
- 2018-03-31: Cash $341.77M.
| Period end | Cash |
|---|---|
| 2018-12-31 | $456.65M 10-K · filed 2019-02-25 |
| 2018-09-30 | $487.30M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $319.74M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $341.77M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $239.76M 10-K · filed 2019-02-25 |
| 2017-09-30 | $253.52M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $272.26M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $288.87M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $315.52M 10-K · filed 2018-03-08 |
| 2016-10-31 | $315.50M 10-K · filed 2017-03-10 |
| 2016-09-30 | $228.61M 10-Q · filed 2016-11-22 |
| 2015-12-31 | $155.96M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |